Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:24 Issue:1 Number:2 ISSN#:2563-5476
Author Verified
ACE Report #13494
Ace Report Cover General Orthopaedics

IV TXA Reduces Blood Loss & Transfusion Rate in Hip Fracture Surgery

How to Cite

OrthoEvidence. IV TXA Reduces Blood Loss & Transfusion Rate in Hip Fracture Surgery. ACE Report. 2021;24(1):2. Available from: https://myorthoevidene.com/AceReport/Report/13494

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial

Bone Joint J. 2021 Mar;103-B(3): 442-448.

Contributing Authors: VS Nikolaou P Masouros T Floros E Chronopoulos M Skertsou GC Babis

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


One hundred and sixty-five elderly patients scheduled to receive a cemented hemiarthroplasty for a subcapital hip fracture (n=64) or intramedullary nailing procedure for intertrochanteric fracture (n=101) were randomized to receive intravenous tranexamic acid (TXA; n=77) or a normal saline placebo (n=88) for the reduction of blood loss and transfusion rates. Outcomes of interest included total blo...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.